RNXT
RenovoRx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.39
+0.84%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+167.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | VOLL MARK · officer: Chief Financial Officer | Purchase | 25,000 | $0.79 |
| Apr 7, 2026 | VOLL MARK · officer: Chief Financial Officer | A-Award | 80,000 | $0.00 |
| Apr 7, 2026 | Agah Ramtin · director, officer: Chief Medical Officer | A-Award | 621,727 | $0.98 |
| Apr 7, 2026 | Bagai Shaun · director, officer: Chief Executive Officer | A-Award | 946,107 | $0.98 |
| Apr 7, 2026 | Gentry Leesa · officer: Chief Clinical Officer | A-Award | 128,550 | $0.98 |
| Mar 27, 2026 | VOLL MARK · officer: Chief Financial Officer | A-Award | 12,380 | $0.00 |
| Mar 24, 2026 | VOLL MARK · officer: Chief Financial Officer | Purchase | 48,600 | $1.93 |
| Mar 24, 2026 | Marton Laurence · director | Purchase | 9,720 | $0.00 |
| Mar 24, 2026 | Bagai Shaun · director, officer: Chief Executive Officer | Purchase | 12,150 | $1.93 |
| Mar 24, 2026 | Bagai Shaun · director, officer: Chief Executive Officer | Purchase | 24,300 | $0.00 |
| Mar 24, 2026 | Marton Laurence · director | Purchase | 4,860 | $1.93 |
| Mar 24, 2026 | VOLL MARK · officer: Chief Financial Officer | Purchase | 97,200 | $0.00 |
| Jan 22, 2026 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 10,000 | $1.00 |
| Jan 5, 2026 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 9,795 | $0.86 |
| Jan 2, 2026 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 205 | $0.83 |
| Dec 22, 2025 | Bagai Shaun · director, officer: Chief Executive Officer | Purchase | 5,000 | $0.90 |
| Dec 19, 2025 | Bagai Shaun · director, officer: Chief Executive Officer | Purchase | 5,000 | $0.85 |
| Dec 17, 2025 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 12,000 | $0.85 |
| Dec 8, 2025 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 10,000 | $0.96 |
| Nov 24, 2025 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 12,000 | $0.80 |
| Nov 24, 2025 | Agah Ramtin · director, officer: Chief Medical Officer | Purchase | 10,000 | $0.80 |
| Oct 3, 2025 | Marton Laurence · director | A-Award | 47,640 | $1.34 |
| Oct 2, 2025 | Macfarlane K. Angela · director | A-Award | 47,640 | $1.34 |
| Oct 2, 2025 | Spiegel Robert J. · director | A-Award | 47,640 | $1.34 |
| Oct 2, 2025 | RYAN UNA S · director | A-Award | 47,640 | $1.34 |
| Aug 26, 2025 | Bagai Shaun · director, officer: Chief Executive Officer | Purchase | 5,000 | $0.91 |
| Jul 3, 2025 | Bagai Shaun · director, officer: Chief Executive Officer | A-Award | 102,498 | $1.27 |
| Jul 3, 2025 | Kocak Ron · officer: VP, Controller and PAO | A-Award | 41,600 | $1.27 |
| Jul 3, 2025 | Agah Ramtin · director, officer: Chief Medical Officer | A-Award | 63,636 | $1.27 |
| Jul 3, 2025 | Gentry Leesa · officer: Chief Clinical Officer | A-Award | 6,619 | $1.27 |
Institutional positioning
13F filings over the trailing two quarters
New 7Increased 19Reduced 10Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| AIGH Capital Management LLC | Increased | 4,405,439 | Aug 7, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Increased | 3,706,197 | Apr 30, 2026 |
| Bleichroeder LP | Unchanged | 1,666,098 | Aug 13, 2026 |
| BLEICHROEDER LP | Increased | 1,666,098 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,447,177 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,443,742 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 424,148 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 381,723 | May 15, 2026 |
| Wealthspire Advisors, LLC | Unchanged | 252,525 | Aug 11, 2026 |
| WEALTHSPIRE ADVISORS, LLC | Unchanged | 252,525 | May 1, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 240,330 | Aug 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 232,684 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 157,902 | May 8, 2026 |
| CITADEL ADVISORS LLC | Reduced | 133,597 | Sep 2, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | Increased | 99,460 | May 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 21, 2026